E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/21/2015 in the Prospect News Investment Grade Daily.

S&P affirms CVS Health

Standard & Poor's said it affirmed its BBB+/A-2 long- and short-term corporate credit ratings on CVS Health Corp. and all issue-level ratings on CVS' debt.

The outlook is stable.

S&P said the affirmation follows the company's announcement that it reached a definitive agreement to purchase Omnicare Inc. (BB/stable) in a transaction valued at about $12.7 billion, including the assumption of about $2.3 billion of Omnicare's existing debt. The transaction, which is subject to regulatory approval, is expected to close near the end of 2015.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.